Global site locations
Resilient supply starts with being where you need us globally
To succeed in today’s complex drug development environment, you need a trusted CDMO partner you can depend on.
We provide industry-leading pharma services through our Patheon™ brand, offering an integrated global network of scientific, technical, regulatory, and quality experts. Our teams are committed to helping you deliver medicines to patients faster with a commitment to quality, innovation, and reliability. We believe in strategic partnerships founded on science, technology, and world-class expertise—bonded by key elements such as trust, communication, and collaboration.
Resilient supply starts with being where you need us—across the U.S. and the globe.
- We offer supply chain assurance and business continuity during dynamic market conditions.
- Our expanded network and investments guarantee streamlined development and manufacturing.
- We have the capacity, flexibility, and expertise to meet your evolving needs.
Have questions about our U.S. or global capabilities? Contact us.
Comprehensive, connected capabilities across every phase of development
Our pharma services span the full drug development lifecycle—including API, biologics, viral vectors, cell therapies, formulation, clinical trials solutions, logistics services, commercial manufacturing, and packaging. We combine scientific and technical excellence with a collaborative partnership model to support customers of all sizes through every stage of bringing new therapies to patients.
60+ locations
Thermo Fisher Scientific pharma services spans more than 60 sites across 25 countries
560,000+ clinical shipments completed in 2024
Supporting clinical trial execution and accelerating delivery of safe, high-quality medicines
30 purpose-built GMP facilities
A global clinical trial services network built for supply chain support and regulatory compliance
50+ years of CDMO experience
A legacy of scientific partnership and proven development and manufacturing solutions
Our unique global scale and depth
Meeting growing industry demands is our priority. We are continuously expanding capacity and enhancing capabilities across our global facilities to reinforce our commitment to innovation, reliability, and speed. These investments help you navigate supply chain complexities, regulatory challenges, and global economic shifts—ensuring scalable, high-quality manufacturing solutions when and where you need them. With more than 60 locations in over 25 countries, we support every stage of your drug development journey—whether you need to:
- Create or source your API
- Design the ideal formulation
- Scale to your next clinical trial milestone
- Develop a supply chain strategy
- Ensure production continuity
- Launch commercially with confidence
{{ marker.locationName }}
Capabilities:
Economic Zone:
{{ item.title }}
{{ item.economicZoneName }}
{{ totalVisibleMarkers }} Results found
Asia Pacific (APAC)
Latin America (LatAm)
North America (AMER)
Florence, South Carolina (East), USA
Capabilities:
Florence, South Carolina (West), USA
Capabilities:
Europe Middle East Africa (EMEA)
Featured site: Monza, Italy
Our 642,000 sq. ft. campus in Monza, Italy, is a center of excellence for sterile manufacturing. It features a unique co-location of mRNA manufacturing capabilities with lipid nanoparticle (LNP) and fill-finish services, helping to streamline your processes and proactively mitigate risk.
Capabilities: Steriles, mRNA
Featured site: Greenville, North Carolina, US
Our Greenville, NC, facility is a large, multipurpose pharmaceutical manufacturing and packaging campus. The site provides both solid dose form manufacturing and packaging, as well as sterile dose manufacturing, filling, and lyophilization for biopharmaceuticals and small molecules.
Capabilities: Steriles
Featured site: Ferentino, Italy
Our Ferentino, Italy, facility offers 151,061 sq. ft. of space and specializes in integrated sterile liquid and lyophilized product development and commercial manufacturing, including for high-potency products and LVPs. The facility has high-potency capabilities up to Category 3b.
Capabilities: Steriles
Featured site: Groningen, Netherlands
Our Groningen site in The Netherlands specializes in cGMP preclinical and commercial manufacturing, including mammalian cell culture manufacturing, scale-up, and cGMP manufacturing of recombinant proteins and monoclonal antibodies.
Capabilities: Biologics
Featured site: Lengnau, Switzerland
Our Lengnau facility is a state-of-the-art, multipurpose biomanufacturing site. This 1.5 million sq. ft. facility leverages highly flexible bioproduction technologies, including stainless steel bioreactors with capacities of up to 12,500 L, providing a pathway from development to large-scale production.
Capabilities: Biologics
Featured site: Allentown, Pennsylvania, US
Allentown is our largest ambient and cold packaging, storage, and distribution facility for clinical trials. It has expanded its services to include commercial packaging and serialization, offering primary packaging of oral solid doses in blister packs and bottles, along with secondary packaging services for syringes, prefilled syringes, pens, and autoinjectors, including assembly and labeling.
Capabilities: Clinical supply solutions
Featured site: Basel, Switzerland
Our Basel site offers a comprehensive service line supporting all aspects of clinical trial supply, including primary and secondary packaging, labeling, regulatory support, distribution, returns and destruction, and comparator sourcing. It also supports cold chain supply management and has in-house engineering capabilities for tooling, equipment customization, and production automation.
Capabilities: Clinical supply solutions